false statements

Rosen Law Firm reminds $LU investors of approaching deadline to join securities class action over alleged false statements and control weaknesses.

Medpace faces securities lawsuit alleging false backlog statements. Investors have until June 8, 2026 to join class action claiming overstated growth expectations.

Eos Energy shareholders must file by May 5, 2026, to join securities class action alleging false production capacity and battery performance claims.

Nektar Therapeutics faces securities class action lawsuit alleging false statements about REZOLVE-AA trial. Lead plaintiff deadline set for May 5, 2026.

Rosen Law Firm files securities class action against Boston Scientific, alleging false statements about U.S. Electrophysiology segment sustainability. Investors have until May 4 deadline to join.

Rosen Law Firm sues Camping World Holdings for alleged false statements on inventory, demand, and finances. Investors have until May 11, 2026 to join the class action.

Class action filed against Regencell Bioscience for allegedly false statements on operations and market manipulation vulnerabilities affecting investors during October 2024-October 2025 period.

Class action lawsuit filed against $COTY alleging executives made false statements about growth prospects during November 2025-February 2026 period.

Class action lawsuit filed against Boston Scientific alleging materially false statements about U.S. electrophysiology segment growth. Investors who purchased BSX shares July 2025-February 2026 eligible.

Class action lawsuit filed against $MNDY alleging materially false statements about revenue outlook and sales cycles from September 2025 to February 2026.

Rosen Law Firm sues $ALDX over allegedly false reproxalap trial claims. Investors eligible for compensation; lead plaintiff deadline May 29, 2026.

Rosen Law Firm files class action against $POET Technologies for alleged false PFIC tax statements and failure to disclose negative U.S. shareholder implications.

Rosen Law Firm urges $BW investors to secure counsel before June 15 deadline in securities class action alleging false statements about Applied Digital contract.

Aquestive Therapeutics ($AQST) investors have until May 4, 2026 to join a securities fraud lawsuit alleging the company concealed human factors issues with its Anaphylm sublingual film product.

Rosen Law Firm launches class action against Super Micro Computer for allegedly failing to disclose significant Chinese customer sales and compliance control weaknesses.

Pinterest faces securities lawsuit alleging false statements on ad revenue, tariff management, and restructuring. Eligible investors have until May 29, 2026 deadline.

Rosen Law Firm files securities class action against ODDITY Tech over alleged false statements on customer acquisition costs. Eligible investors have until May 11, 2026 to seek compensation.

Rosen Law Firm alerts $STLA investors of June 8 deadline in class action alleging false statements about EV positioning and earnings growth.

Class action lawsuit filed against $PINS alleges false statements on ad revenues, tariff impacts, and failure to disclose restructuring plans.

Class action lawsuit filed against Apollo Global Management alleging executives made false statements about communications with Jeffrey Epstein, contradicting prior denials.